SCHEMBL2363338

SCHEMBL2363338

C=CCN(OCCCCCCO)OCCCCCCO

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2363819 1.00 ALDH1A1 (0.30) ALDH1A1CYP3A4TSHR
SCHEMBL2363494 0.98 ALDH1A1 (0.30) ALDH1A1
SCHEMBL2363880 0.91 ALDH1A1 (0.31) ALDH1A1
SCHEMBL170619 0.82 TSHR (0.34) TSHR
Water SCHEMBL28567616 0.80 TSHR (0.33) TSHR
Hydrochloric Acid SCHEMBL27548529 0.80 TSHR (0.33) TSHR
Hydroxyamine SCHEMBL27747250 0.78 TSHR (0.32) TSHR
Phosphoric Acid SCHEMBL28205261 0.73 TSHR (0.33) ALDH1A1TSHR
Sulfuric Acid SCHEMBL28816206 0.73 TSHR (0.33) TSHR
SCHEMBL926316 0.71 LMNA (0.42) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718564-B2 Partially decomposed catalyst and hydrocarbon oxidation processes using the same EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2010-05-18 US claimed
US-7605107-B2 Method of preparing a supported hydrotreating catalyst EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-10-20 US claimed
US-7538066-B2 Method of preparing a hydrotreating catalyst on a support containing a rare earth metal EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-05-26 US claimed
US-20070082811-A1 Method of preparing a hydrotreating catalyst on a support containing a rare earth metal EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2007-04-12 US claimed
US-20070072765-A1 Method of preparing a supported hydrotreating catalyst EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2007-03-29 US claimed
EP-2531480-B1 DEHYDROGENATION PROCESS EXXONMOBIL CHEMICAL PATENTS INC (US) 2019-01-16 EP disclosed
US-9035107-B2 Dehydrogenation process EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-05-19 US disclosed
US-9024078-B2 Dehydrogenation process EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-05-05 US disclosed
US-8969639-B2 Dehydrogenation process EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-03-03 US disclosed
US-8884075-B2 Process for producing phenol EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-11-11 US disclosed
US-20140148620-A1 Process for Producing Phenol EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-05-29 US disclosed
US-20120323046-A1 Dehydrogenation Process EXXONMOBIL CHEMICAL PATENTS INC. 2012-12-20 US disclosed
US-20120302798-A1 Dehydrogenation Process EXXONMOBIL CHEMICAL PATENTS INC. 2012-11-29 US disclosed
US-20120271077-A1 Dehydrogenation Process EXXONMOBILE CHEMICAL PATENTS INC. (US) 2012-10-25 US disclosed
WO-2012050665-A1 PROCESS FOR PRODUCING PHENOL EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-04-19 WO disclosed
WO-2011096992-A1 DEHYDROGENATION PROCESS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-08-11 WO disclosed
WO-2011096997-A1 DEHYDROGENATION PROCESS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-08-11 WO disclosed
WO-2011096994-A1 DEHYDROGENATION PROCESS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-08-11 WO disclosed
US-7718564-B2 Partially decomposed catalyst and hydrocarbon oxidation processes using the same EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2010-05-18 US disclosed
US-20060293544-A1 Partially decomposed catalyst and hydrocarbon oxidation processes using the same EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148620-A1 Process for Producing Phenol HPD, CYP2J2, CYP2E1 ALDH1A1 1756/4885CYP3A4 8/4885TSHR 4291/4885
US-20120271077-A1 Dehydrogenation Process ADH5, ADH1A, ADH1C ALDH1A1 40/4885CYP3A4 10/4885TSHR 4452/4885
US-20120302798-A1 Dehydrogenation Process NDUFV1, NDUFV2, MAFG ALDH1A1 274/4885CYP3A4 115/4885TSHR 4824/4885
US-20120323046-A1 Dehydrogenation Process ADH1A, ADH5, ADH1C ALDH1A1 85/4885CYP3A4 43/4885TSHR 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.